Piper Sandler Maintains Overweight on Colgate-Palmolive, Lowers Price Target to $92

Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $96 to $92.